Found 30 matching trials
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 PHASE3 Phase 1
* To evaluate the safety and tolerability of REGN10933+REGN10987 c...
Show More Location
Regeneron Study Site
Learn More & Join Trial
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting PHASE2 No therapeutic agent is currently approved for the treatment of SARSCoV-2 i...
Show More Location
DHR Health Institute for Research and Development
Learn More & Join Trial
Compassionate Use of REGN-COV2 for the Treatment of COVID-19 N/A Compassionate Use requests will be considered for individuals who test posi...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB) N/A Absence of anti-SARS-CoV-2 vaccine response or insufficient vaccine respons...
Show More Location
Assistance Publique - HĂ´pitaux de Paris (AP-HP) - Cochin Hospital
Learn More & Join Trial
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) PHASE2 The trial will develop and validate a platform for quantitative assessment ...
Show More Location
Universidade Federal de Minas Gerais
Learn More & Join Trial
Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19 PHASE3 * Research Question: Does convalescent plasma (CCP) collected from donors w...
Show More Learn More & Join Trial
COVID-19 International Drug Pregnancy Registry N/A The objective of the COVID-19 International Drug Pregnancy Registry (COVID-...
Show More Learn More & Join Trial
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) PHASE1 The human immune system is designed to protect individuals from external so...
Show More Location
All Natural Medicine Clinic, LLC
Learn More & Join Trial
Treatment of Nosocomial COVID-19 PHASE4 COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2...
Show More Location
University of Calgary
Learn More & Join Trial
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19 PHASE1 The primary objectives of the study are:
* To characterize the concentrati...
Show More Location
State University of New York at Stony Brook
Learn More & Join Trial